Role of p16 testing in cervical cancer screening among HIV-infected women.

Christine J McGrathRochelle GarciaTrong T TrinhBarbra A RichardsonGrace C John-StewartEvans Nyongesa-MalavaNelly R MugoEmily H GlynnSamah R SakrHugo De VuystMichael H Chung

Published in: PloS one (2017)

As an adjunctive test in HIV-infected women, p16 immunohistochemistry increased specificity and PPV of HPV and VIA for CIN2/3, and was not altered in performance by immunosuppression, ART, or age.

Keyphrases

cervical cancer screening
hiv infected
antiretroviral therapy
human immunodeficiency virus
polycystic ovary syndrome
type diabetes
metabolic syndrome
adipose tissue